Opioid pharmacokinetic drug-drug interactions
- PMID: 21999760
Opioid pharmacokinetic drug-drug interactions
Abstract
Pharmacokinetic drug-drug interactions (DDIs) involving opioid analgesics can be problematic. Opioids are widely used, have a narrow therapeutic index, and can be associated with severe toxicity. The purpose of this review is to describe pharmacokinetic DDIs associated with opioids frequently encountered in managed care settings (morphine, codeine, oxycodone, oxymorphone, hydrocodone, hydromorphone, fentanyl, tramadol, and methadone). An introduction to the pharmacokinetic basis of DDIs is provided, and potential DDIs associated with opioids are reviewed. Opioids metabolized by the drug metabolizing enzymes of the cytochrome P450 (CYP450) system (codeine, oxycodone, hydrocodone, fentanyl, tramadol, and methadone) are associated with numerous DDIs that can result in either a reduction in opioid effect or excess opioid effects. Conversely, opioids that are not metabolized by that system (morphine, oxymorphone, and hydromorphone) tend to be involved in fewer CYP450-associated pharmacokinetic DDIs.
Similar articles
-
Quantifying the impact of drug-drug interactions associated with opioids.Am J Manag Care. 2011 Sep;17 Suppl 11:S288-92. Am J Manag Care. 2011. PMID: 21999761
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids.Pain Pract. 2011 May-Jun;11(3):230-9. doi: 10.1111/j.1533-2500.2010.00413.x. Epub 2010 Aug 27. Pain Pract. 2011. PMID: 20807350
-
Metabolism and Disposition of Prescription Opioids: A Review.Forensic Sci Rev. 2015 Jul;27(2):115-45. Forensic Sci Rev. 2015. PMID: 26227254 Review.
-
Economic impact of potential drug-drug interactions in opioid analgesics.J Med Econ. 2011;14(4):390-6. doi: 10.3111/13696998.2011.583302. Epub 2011 May 17. J Med Econ. 2011. PMID: 21574905
Cited by
-
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice.Pharmaceutics. 2023 Apr 6;15(4):1165. doi: 10.3390/pharmaceutics15041165. Pharmaceutics. 2023. PMID: 37111650 Free PMC article. Review.
-
Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors.Support Care Cancer. 2019 Feb;27(2):351-371. doi: 10.1007/s00520-018-4508-3. Epub 2018 Oct 20. Support Care Cancer. 2019. PMID: 30343412
-
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors.JAMA Netw Open. 2022 Feb 1;5(2):e220194. doi: 10.1001/jamanetworkopen.2022.0194. JAMA Netw Open. 2022. PMID: 35201310 Free PMC article.
-
Bioequivalence, Drugs with Narrow Therapeutic Index and The Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution.Healthcare (Basel). 2022 Jul 26;10(8):1392. doi: 10.3390/healthcare10081392. Healthcare (Basel). 2022. PMID: 35893214 Free PMC article. Review.
-
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty.J Pain Res. 2017 Oct 6;10:2413-2424. doi: 10.2147/JPR.S137952. eCollection 2017. J Pain Res. 2017. PMID: 29062240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
